Company Filing History:
1 out of 818 
1 out of 1,209 
Years Active: 2008
Title: Michael Bergwelt-Baildon: Innovator in Cancer Immunotherapy
Introduction
Michael Bergwelt-Baildon is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, particularly in immunotherapy. His innovative work focuses on utilizing cytochrome P450 1B1 for cancer diagnosis and treatment.
Latest Patents
Michael holds a patent for "Cancer immunotherapy and diagnosis using cytochrome P450 1B1." This invention provides methods for conducting cancer immunotherapy and diagnosis using cytochrome P450 1B1 and peptide fragments thereof. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Michael has worked with esteemed institutions such as Boston University and Dana-Farber Cancer Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Michael has collaborated with notable colleagues, including Joachim L. Schultze and Robert H. Vonderheide. These partnerships have further enriched his research and contributed to the development of innovative cancer therapies.
Conclusion
Michael Bergwelt-Baildon is a dedicated inventor whose work in cancer immunotherapy is paving the way for new diagnostic and treatment methods. His contributions to the field are invaluable and continue to inspire future innovations.